Aarti Pharmalabs Past Earnings Performance
Past criteria checks 3/6
Aarti Pharmalabs has been growing earnings at an average annual rate of 38.4%, while the Pharmaceuticals industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 32% per year. Aarti Pharmalabs's return on equity is 12.3%, and it has net margins of 11.7%.
Key information
38.4%
Earnings growth rate
43.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 32.0% |
| Return on equity | 12.3% |
| Net Margin | 11.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Aarti Pharmalabs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 18,526 | 2,169 | 1,384 | 0 |
| 31 Dec 23 | 18,319 | 1,945 | 1,394 | 0 |
| 30 Sep 23 | 18,548 | 1,895 | 1,380 | 0 |
| 30 Jun 23 | 19,462 | 1,887 | 1,325 | 0 |
| 31 Mar 23 | 19,452 | 1,935 | 1,349 | 0 |
| 31 Dec 22 | 20,601 | 2,118 | 1,391 | 0 |
| 30 Sep 22 | 21,885 | 2,252 | 1,469 | 0 |
| 30 Jun 22 | 16,573 | 1,741 | 1,156 | 0 |
| 31 Mar 22 | 11,999 | 1,223 | 852 | 0 |
| 31 Mar 21 | 0 | 0 | 0 | 0 |
Quality Earnings: AARTIPHARM has high quality earnings.
Growing Profit Margin: AARTIPHARM's current net profit margins (11.7%) are higher than last year (9.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AARTIPHARM's earnings have grown significantly by 38.4% per year over the past 5 years.
Accelerating Growth: AARTIPHARM's earnings growth over the past year (12.1%) is below its 5-year average (38.4% per year).
Earnings vs Industry: AARTIPHARM earnings growth over the past year (12.1%) did not outperform the Pharmaceuticals industry 18.2%.
Return on Equity
High ROE: AARTIPHARM's Return on Equity (12.3%) is considered low.